Global Bacteriophage Therapy Supply, Demand and Key Producers, 2023-2029

Description

The global Bacteriophage Therapy market size is expected to reach $ 61 million by 2029, rising at a market growth of 9.2% CAGR during the forecast period (2023-2029).

The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

This report studies the global Bacteriophage Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Bacteriophage Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bacteriophage Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Bacteriophage Therapy total market, 2018-2029, (USD Million)
Global Bacteriophage Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Bacteriophage Therapy total market, key domestic companies and share, (USD Million)
Global Bacteriophage Therapy revenue by player and market share 2018-2023, (USD Million)
Global Bacteriophage Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Bacteriophage Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Bacteriophage Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc. and TechnoPhage, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Bacteriophage Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Bacteriophage Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Bacteriophage Therapy Market, Segmentation by Type
    Oral
    Topical
    Parenteral

Global Bacteriophage Therapy Market, Segmentation by Application
    Organ Transplantation
    Bacterial Infections
    Alcoholic Hepatitis
    Other

Companies Profiled:
    Armata Pharmaceuticals, Inc.
    Eliava Biopreparations Ltd.
    Pherecydes Pharma
    Intralytix, Inc.
    Phagelux Inc.
    Nextbiotics
    InnoPhage, Ltd
    Locus Biosciences, Inc.
    TechnoPhage
    Eligo Bioscience SA
    Phagomed Biopharma GmbH.
    PhagePro, Inc.
    Adaptive Phage Therapeutics, Inc.
    EnBiotix, Inc.
    Intodeworld, Inc.
    BiomX Ltd.
    Phi Therapeutics
    Fixed-phage Ltd.
    Micreos BV
    ContraFect Corporation

Key Questions Answered
1. How big is the global Bacteriophage Therapy market?
2. What is the demand of the global Bacteriophage Therapy market?
3. What is the year over year growth of the global Bacteriophage Therapy market?
4. What is the total value of the global Bacteriophage Therapy market?
5. Who are the major players in the global Bacteriophage Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Bacteriophage Therapy Introduction
    1.2 World Bacteriophage Therapy Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Bacteriophage Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Bacteriophage Therapy Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Bacteriophage Therapy Market Size (2018-2029)
        1.3.3 China Bacteriophage Therapy Market Size (2018-2029)
        1.3.4 Europe Bacteriophage Therapy Market Size (2018-2029)
        1.3.5 Japan Bacteriophage Therapy Market Size (2018-2029)
        1.3.6 South Korea Bacteriophage Therapy Market Size (2018-2029)
        1.3.7 ASEAN Bacteriophage Therapy Market Size (2018-2029)
        1.3.8 India Bacteriophage Therapy Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Bacteriophage Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Bacteriophage Therapy Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Bacteriophage Therapy Consumption Value (2018-2029)
    2.2 World Bacteriophage Therapy Consumption Value by Region
        2.2.1 World Bacteriophage Therapy Consumption Value by Region (2018-2023)
        2.2.2 World Bacteriophage Therapy Consumption Value Forecast by Region (2024-2029)
    2.3 United States Bacteriophage Therapy Consumption Value (2018-2029)
    2.4 China Bacteriophage Therapy Consumption Value (2018-2029)
    2.5 Europe Bacteriophage Therapy Consumption Value (2018-2029)
    2.6 Japan Bacteriophage Therapy Consumption Value (2018-2029)
    2.7 South Korea Bacteriophage Therapy Consumption Value (2018-2029)
    2.8 ASEAN Bacteriophage Therapy Consumption Value (2018-2029)
    2.9 India Bacteriophage Therapy Consumption Value (2018-2029)

3 World Bacteriophage Therapy Companies Competitive Analysis
    3.1 World Bacteriophage Therapy Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Bacteriophage Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Bacteriophage Therapy in 2022
        3.2.3 Global Concentration Ratios (CR8) for Bacteriophage Therapy in 2022
    3.3 Bacteriophage Therapy Company Evaluation Quadrant
    3.4 Bacteriophage Therapy Market: Overall Company Footprint Analysis
        3.4.1 Bacteriophage Therapy Market: Region Footprint
        3.4.2 Bacteriophage Therapy Market: Company Product Type Footprint
        3.4.3 Bacteriophage Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Bacteriophage Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Bacteriophage Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Bacteriophage Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Bacteriophage Therapy Consumption Value Comparison
        4.2.1 United States VS China: Bacteriophage Therapy Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Bacteriophage Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Bacteriophage Therapy Companies and Market Share, 2018-2023
        4.3.1 United States Based Bacteriophage Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Bacteriophage Therapy Revenue, (2018-2023)
    4.4 China Based Companies Bacteriophage Therapy Revenue and Market Share, 2018-2023
        4.4.1 China Based Bacteriophage Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Bacteriophage Therapy Revenue, (2018-2023)
    4.5 Rest of World Based Bacteriophage Therapy Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Bacteriophage Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Bacteriophage Therapy Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Bacteriophage Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Oral
        5.2.2 Topical
        5.2.3 Parenteral
    5.3 Market Segment by Type
        5.3.1 World Bacteriophage Therapy Market Size by Type (2018-2023)
        5.3.2 World Bacteriophage Therapy Market Size by Type (2024-2029)
        5.3.3 World Bacteriophage Therapy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Bacteriophage Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Organ Transplantation
        6.2.2 Bacterial Infections
        6.2.3 Alcoholic Hepatitis
        6.2.4 Other
        6.2.5 Other
    6.3 Market Segment by Application
        6.3.1 World Bacteriophage Therapy Market Size by Application (2018-2023)
        6.3.2 World Bacteriophage Therapy Market Size by Application (2024-2029)
        6.3.3 World Bacteriophage Therapy Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Armata Pharmaceuticals, Inc.
        7.1.1 Armata Pharmaceuticals, Inc. Details
        7.1.2 Armata Pharmaceuticals, Inc. Major Business
        7.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product and Services
        7.1.4 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Armata Pharmaceuticals, Inc. Recent Developments/Updates
        7.1.6 Armata Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    7.2 Eliava Biopreparations Ltd.
        7.2.1 Eliava Biopreparations Ltd. Details
        7.2.2 Eliava Biopreparations Ltd. Major Business
        7.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Product and Services
        7.2.4 Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Eliava Biopreparations Ltd. Recent Developments/Updates
        7.2.6 Eliava Biopreparations Ltd. Competitive Strengths & Weaknesses
    7.3 Pherecydes Pharma
        7.3.1 Pherecydes Pharma Details
        7.3.2 Pherecydes Pharma Major Business
        7.3.3 Pherecydes Pharma Bacteriophage Therapy Product and Services
        7.3.4 Pherecydes Pharma Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Pherecydes Pharma Recent Developments/Updates
        7.3.6 Pherecydes Pharma Competitive Strengths & Weaknesses
    7.4 Intralytix, Inc.
        7.4.1 Intralytix, Inc. Details
        7.4.2 Intralytix, Inc. Major Business
        7.4.3 Intralytix, Inc. Bacteriophage Therapy Product and Services
        7.4.4 Intralytix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Intralytix, Inc. Recent Developments/Updates
        7.4.6 Intralytix, Inc. Competitive Strengths & Weaknesses
    7.5 Phagelux Inc.
        7.5.1 Phagelux Inc. Details
        7.5.2 Phagelux Inc. Major Business
        7.5.3 Phagelux Inc. Bacteriophage Therapy Product and Services
        7.5.4 Phagelux Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Phagelux Inc. Recent Developments/Updates
        7.5.6 Phagelux Inc. Competitive Strengths & Weaknesses
    7.6 Nextbiotics
        7.6.1 Nextbiotics Details
        7.6.2 Nextbiotics Major Business
        7.6.3 Nextbiotics Bacteriophage Therapy Product and Services
        7.6.4 Nextbiotics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Nextbiotics Recent Developments/Updates
        7.6.6 Nextbiotics Competitive Strengths & Weaknesses
    7.7 InnoPhage, Ltd
        7.7.1 InnoPhage, Ltd Details
        7.7.2 InnoPhage, Ltd Major Business
        7.7.3 InnoPhage, Ltd Bacteriophage Therapy Product and Services
        7.7.4 InnoPhage, Ltd Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 InnoPhage, Ltd Recent Developments/Updates
        7.7.6 InnoPhage, Ltd Competitive Strengths & Weaknesses
    7.8 Locus Biosciences, Inc.
        7.8.1 Locus Biosciences, Inc. Details
        7.8.2 Locus Biosciences, Inc. Major Business
        7.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Product and Services
        7.8.4 Locus Biosciences, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Locus Biosciences, Inc. Recent Developments/Updates
        7.8.6 Locus Biosciences, Inc. Competitive Strengths & Weaknesses
    7.9 TechnoPhage
        7.9.1 TechnoPhage Details
        7.9.2 TechnoPhage Major Business
        7.9.3 TechnoPhage Bacteriophage Therapy Product and Services
        7.9.4 TechnoPhage Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 TechnoPhage Recent Developments/Updates
        7.9.6 TechnoPhage Competitive Strengths & Weaknesses
    7.10 Eligo Bioscience SA
        7.10.1 Eligo Bioscience SA Details
        7.10.2 Eligo Bioscience SA Major Business
        7.10.3 Eligo Bioscience SA Bacteriophage Therapy Product and Services
        7.10.4 Eligo Bioscience SA Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Eligo Bioscience SA Recent Developments/Updates
        7.10.6 Eligo Bioscience SA Competitive Strengths & Weaknesses
    7.11 Phagomed Biopharma GmbH.
        7.11.1 Phagomed Biopharma GmbH. Details
        7.11.2 Phagomed Biopharma GmbH. Major Business
        7.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Product and Services
        7.11.4 Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Phagomed Biopharma GmbH. Recent Developments/Updates
        7.11.6 Phagomed Biopharma GmbH. Competitive Strengths & Weaknesses
    7.12 PhagePro, Inc.
        7.12.1 PhagePro, Inc. Details
        7.12.2 PhagePro, Inc. Major Business
        7.12.3 PhagePro, Inc. Bacteriophage Therapy Product and Services
        7.12.4 PhagePro, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 PhagePro, Inc. Recent Developments/Updates
        7.12.6 PhagePro, Inc. Competitive Strengths & Weaknesses
    7.13 Adaptive Phage Therapeutics, Inc.
        7.13.1 Adaptive Phage Therapeutics, Inc. Details
        7.13.2 Adaptive Phage Therapeutics, Inc. Major Business
        7.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product and Services
        7.13.4 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Adaptive Phage Therapeutics, Inc. Recent Developments/Updates
        7.13.6 Adaptive Phage Therapeutics, Inc. Competitive Strengths & Weaknesses
    7.14 EnBiotix, Inc.
        7.14.1 EnBiotix, Inc. Details
        7.14.2 EnBiotix, Inc. Major Business
        7.14.3 EnBiotix, Inc. Bacteriophage Therapy Product and Services
        7.14.4 EnBiotix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 EnBiotix, Inc. Recent Developments/Updates
        7.14.6 EnBiotix, Inc. Competitive Strengths & Weaknesses
    7.15 Intodeworld, Inc.
        7.15.1 Intodeworld, Inc. Details
        7.15.2 Intodeworld, Inc. Major Business
        7.15.3 Intodeworld, Inc. Bacteriophage Therapy Product and Services
        7.15.4 Intodeworld, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Intodeworld, Inc. Recent Developments/Updates
        7.15.6 Intodeworld, Inc. Competitive Strengths & Weaknesses
    7.16 BiomX Ltd.
        7.16.1 BiomX Ltd. Details
        7.16.2 BiomX Ltd. Major Business
        7.16.3 BiomX Ltd. Bacteriophage Therapy Product and Services
        7.16.4 BiomX Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 BiomX Ltd. Recent Developments/Updates
        7.16.6 BiomX Ltd. Competitive Strengths & Weaknesses
    7.17 Phi Therapeutics
        7.17.1 Phi Therapeutics Details
        7.17.2 Phi Therapeutics Major Business
        7.17.3 Phi Therapeutics Bacteriophage Therapy Product and Services
        7.17.4 Phi Therapeutics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Phi Therapeutics Recent Developments/Updates
        7.17.6 Phi Therapeutics Competitive Strengths & Weaknesses
    7.18 Fixed-phage Ltd.
        7.18.1 Fixed-phage Ltd. Details
        7.18.2 Fixed-phage Ltd. Major Business
        7.18.3 Fixed-phage Ltd. Bacteriophage Therapy Product and Services
        7.18.4 Fixed-phage Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Fixed-phage Ltd. Recent Developments/Updates
        7.18.6 Fixed-phage Ltd. Competitive Strengths & Weaknesses
    7.19 Micreos BV
        7.19.1 Micreos BV Details
        7.19.2 Micreos BV Major Business
        7.19.3 Micreos BV Bacteriophage Therapy Product and Services
        7.19.4 Micreos BV Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.19.5 Micreos BV Recent Developments/Updates
        7.19.6 Micreos BV Competitive Strengths & Weaknesses
    7.20 ContraFect Corporation
        7.20.1 ContraFect Corporation Details
        7.20.2 ContraFect Corporation Major Business
        7.20.3 ContraFect Corporation Bacteriophage Therapy Product and Services
        7.20.4 ContraFect Corporation Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.20.5 ContraFect Corporation Recent Developments/Updates
        7.20.6 ContraFect Corporation Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Bacteriophage Therapy Industry Chain
    8.2 Bacteriophage Therapy Upstream Analysis
    8.3 Bacteriophage Therapy Midstream Analysis
    8.4 Bacteriophage Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Bacteriophage Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Bacteriophage Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Bacteriophage Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Bacteriophage Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Bacteriophage Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Bacteriophage Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Bacteriophage Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Bacteriophage Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Bacteriophage Therapy Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Bacteriophage Therapy Players in 2022
    Table 12. World Bacteriophage Therapy Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Bacteriophage Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Bacteriophage Therapy Player
    Table 15. Bacteriophage Therapy Market: Company Product Type Footprint
    Table 16. Bacteriophage Therapy Market: Company Product Application Footprint
    Table 17. Bacteriophage Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Bacteriophage Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Bacteriophage Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Bacteriophage Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Bacteriophage Therapy Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Bacteriophage Therapy Revenue Market Share (2018-2023)
    Table 23. China Based Bacteriophage Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Bacteriophage Therapy Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Bacteriophage Therapy Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Bacteriophage Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Bacteriophage Therapy Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Bacteriophage Therapy Revenue Market Share (2018-2023)
    Table 29. World Bacteriophage Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Bacteriophage Therapy Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Bacteriophage Therapy Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Bacteriophage Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Bacteriophage Therapy Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Bacteriophage Therapy Market Size by Application (2024-2029) & (USD Million)
    Table 35. Armata Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
    Table 36. Armata Pharmaceuticals, Inc. Major Business
    Table 37. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product and Services
    Table 38. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Armata Pharmaceuticals, Inc. Recent Developments/Updates
    Table 40. Armata Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    Table 41. Eliava Biopreparations Ltd. Basic Information, Area Served and Competitors
    Table 42. Eliava Biopreparations Ltd. Major Business
    Table 43. Eliava Biopreparations Ltd. Bacteriophage Therapy Product and Services
    Table 44. Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Eliava Biopreparations Ltd. Recent Developments/Updates
    Table 46. Eliava Biopreparations Ltd. Competitive Strengths & Weaknesses
    Table 47. Pherecydes Pharma Basic Information, Area Served and Competitors
    Table 48. Pherecydes Pharma Major Business
    Table 49. Pherecydes Pharma Bacteriophage Therapy Product and Services
    Table 50. Pherecydes Pharma Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Pherecydes Pharma Recent Developments/Updates
    Table 52. Pherecydes Pharma Competitive Strengths & Weaknesses
    Table 53. Intralytix, Inc. Basic Information, Area Served and Competitors
    Table 54. Intralytix, Inc. Major Business
    Table 55. Intralytix, Inc. Bacteriophage Therapy Product and Services
    Table 56. Intralytix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Intralytix, Inc. Recent Developments/Updates
    Table 58. Intralytix, Inc. Competitive Strengths & Weaknesses
    Table 59. Phagelux Inc. Basic Information, Area Served and Competitors
    Table 60. Phagelux Inc. Major Business
    Table 61. Phagelux Inc. Bacteriophage Therapy Product and Services
    Table 62. Phagelux Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Phagelux Inc. Recent Developments/Updates
    Table 64. Phagelux Inc. Competitive Strengths & Weaknesses
    Table 65. Nextbiotics Basic Information, Area Served and Competitors
    Table 66. Nextbiotics Major Business
    Table 67. Nextbiotics Bacteriophage Therapy Product and Services
    Table 68. Nextbiotics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Nextbiotics Recent Developments/Updates
    Table 70. Nextbiotics Competitive Strengths & Weaknesses
    Table 71. InnoPhage, Ltd Basic Information, Area Served and Competitors
    Table 72. InnoPhage, Ltd Major Business
    Table 73. InnoPhage, Ltd Bacteriophage Therapy Product and Services
    Table 74. InnoPhage, Ltd Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. InnoPhage, Ltd Recent Developments/Updates
    Table 76. InnoPhage, Ltd Competitive Strengths & Weaknesses
    Table 77. Locus Biosciences, Inc. Basic Information, Area Served and Competitors
    Table 78. Locus Biosciences, Inc. Major Business
    Table 79. Locus Biosciences, Inc. Bacteriophage Therapy Product and Services
    Table 80. Locus Biosciences, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Locus Biosciences, Inc. Recent Developments/Updates
    Table 82. Locus Biosciences, Inc. Competitive Strengths & Weaknesses
    Table 83. TechnoPhage Basic Information, Area Served and Competitors
    Table 84. TechnoPhage Major Business
    Table 85. TechnoPhage Bacteriophage Therapy Product and Services
    Table 86. TechnoPhage Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. TechnoPhage Recent Developments/Updates
    Table 88. TechnoPhage Competitive Strengths & Weaknesses
    Table 89. Eligo Bioscience SA Basic Information, Area Served and Competitors
    Table 90. Eligo Bioscience SA Major Business
    Table 91. Eligo Bioscience SA Bacteriophage Therapy Product and Services
    Table 92. Eligo Bioscience SA Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Eligo Bioscience SA Recent Developments/Updates
    Table 94. Eligo Bioscience SA Competitive Strengths & Weaknesses
    Table 95. Phagomed Biopharma GmbH. Basic Information, Area Served and Competitors
    Table 96. Phagomed Biopharma GmbH. Major Business
    Table 97. Phagomed Biopharma GmbH. Bacteriophage Therapy Product and Services
    Table 98. Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Phagomed Biopharma GmbH. Recent Developments/Updates
    Table 100. Phagomed Biopharma GmbH. Competitive Strengths & Weaknesses
    Table 101. PhagePro, Inc. Basic Information, Area Served and Competitors
    Table 102. PhagePro, Inc. Major Business
    Table 103. PhagePro, Inc. Bacteriophage Therapy Product and Services
    Table 104. PhagePro, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. PhagePro, Inc. Recent Developments/Updates
    Table 106. PhagePro, Inc. Competitive Strengths & Weaknesses
    Table 107. Adaptive Phage Therapeutics, Inc. Basic Information, Area Served and Competitors
    Table 108. Adaptive Phage Therapeutics, Inc. Major Business
    Table 109. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product and Services
    Table 110. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Adaptive Phage Therapeutics, Inc. Recent Developments/Updates
    Table 112. Adaptive Phage Therapeutics, Inc. Competitive Strengths & Weaknesses
    Table 113. EnBiotix, Inc. Basic Information, Area Served and Competitors
    Table 114. EnBiotix, Inc. Major Business
    Table 115. EnBiotix, Inc. Bacteriophage Therapy Product and Services
    Table 116. EnBiotix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. EnBiotix, Inc. Recent Developments/Updates
    Table 118. EnBiotix, Inc. Competitive Strengths & Weaknesses
    Table 119. Intodeworld, Inc. Basic Information, Area Served and Competitors
    Table 120. Intodeworld, Inc. Major Business
    Table 121. Intodeworld, Inc. Bacteriophage Therapy Product and Services
    Table 122. Intodeworld, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Intodeworld, Inc. Recent Developments/Updates
    Table 124. Intodeworld, Inc. Competitive Strengths & Weaknesses
    Table 125. BiomX Ltd. Basic Information, Area Served and Competitors
    Table 126. BiomX Ltd. Major Business
    Table 127. BiomX Ltd. Bacteriophage Therapy Product and Services
    Table 128. BiomX Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. BiomX Ltd. Recent Developments/Updates
    Table 130. BiomX Ltd. Competitive Strengths & Weaknesses
    Table 131. Phi Therapeutics Basic Information, Area Served and Competitors
    Table 132. Phi Therapeutics Major Business
    Table 133. Phi Therapeutics Bacteriophage Therapy Product and Services
    Table 134. Phi Therapeutics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Phi Therapeutics Recent Developments/Updates
    Table 136. Phi Therapeutics Competitive Strengths & Weaknesses
    Table 137. Fixed-phage Ltd. Basic Information, Area Served and Competitors
    Table 138. Fixed-phage Ltd. Major Business
    Table 139. Fixed-phage Ltd. Bacteriophage Therapy Product and Services
    Table 140. Fixed-phage Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 141. Fixed-phage Ltd. Recent Developments/Updates
    Table 142. Fixed-phage Ltd. Competitive Strengths & Weaknesses
    Table 143. Micreos BV Basic Information, Area Served and Competitors
    Table 144. Micreos BV Major Business
    Table 145. Micreos BV Bacteriophage Therapy Product and Services
    Table 146. Micreos BV Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 147. Micreos BV Recent Developments/Updates
    Table 148. ContraFect Corporation Basic Information, Area Served and Competitors
    Table 149. ContraFect Corporation Major Business
    Table 150. ContraFect Corporation Bacteriophage Therapy Product and Services
    Table 151. ContraFect Corporation Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 152. Global Key Players of Bacteriophage Therapy Upstream (Raw Materials)
    Table 153. Bacteriophage Therapy Typical Customers
List of Figure
    Figure 1. Bacteriophage Therapy Picture
    Figure 2. World Bacteriophage Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Bacteriophage Therapy Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Bacteriophage Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Bacteriophage Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Bacteriophage Therapy Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Bacteriophage Therapy Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Bacteriophage Therapy Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Bacteriophage Therapy Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Bacteriophage Therapy Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Bacteriophage Therapy Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Bacteriophage Therapy Revenue (2018-2029) & (USD Million)
    Figure 13. Bacteriophage Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Bacteriophage Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Bacteriophage Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Bacteriophage Therapy by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Bacteriophage Therapy Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Bacteriophage Therapy Markets in 2022
    Figure 27. United States VS China: Bacteriophage Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Bacteriophage Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Bacteriophage Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Bacteriophage Therapy Market Size Market Share by Type in 2022
    Figure 31. Oral
    Figure 32. Topical
    Figure 33. Parenteral
    Figure 34. World Bacteriophage Therapy Market Size Market Share by Type (2018-2029)
    Figure 35. World Bacteriophage Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Bacteriophage Therapy Market Size Market Share by Application in 2022
    Figure 37. Organ Transplantation
    Figure 38. Bacterial Infections
    Figure 39. Alcoholic Hepatitis
    Figure 40. Other
    Figure 41. Bacteriophage Therapy Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Companies Mentioned

Armata Pharmaceuticals, Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix, Inc.
Phagelux Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro, Inc.
Adaptive Phage Therapeutics, Inc.
EnBiotix, Inc.
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation